foxo4 dri senolytic 2023 2024 foxo4-dri peptide human trial FOXO4-DRI UK The disordered p53 transactivation domain
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications A nutrigeroscience approach: Dietary macronutrients and cellular senescence: Cell Metabolism FOXO4 DRI Results: What to Expect (2026) FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



